TMS Therapy Results

NeuroStar TMS Therapy is indicated for the treatment of depression in adults who have failed to achieve improvement from one prior antidepressant medication. In general, it is used for patients who have tried several antidepressant medications for their depression, with one given long enough and at a high enough dose that it should have been effective but is not. NeuroStar TMS Therapy has not been studied in patients with depression who have not tried antidepressant medications.

The results from the NeuroStar clinical trials were positive. In the NeuroStar open-label clinical trial, which is most like real world practice,

  • 1 in 2 patients treated with NeuroStar TMS  experienced significant improvement in their depression symptoms
  • 1 in 3 patients were in remission, or depression-free, at the end of 6 weeks of treatment.
  • Patients treated with NeuroStar TMS Therapy also experienced significant improvement in anxiety and physical symptoms that include appetite changes, aches and pains, and lack of energy that are associated with depression.

Research on Transcranial Magnetic Stimulation

_______________________________________________

Next: Safety

 

Clinical Depression is a medical disorder characterized by feelings of sadness, hopelessness, pessimism, guilt, and a general loss of interest in life, combined with a sense of reduced emotional well-being and low energy. People with depression also tend to have disturbed sleep, reduced appetite and may even feel suicidal.